Samsung Pharmaceutical Co., Ltd. completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd.
Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd. on October 5, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,180 KRW | +1.57% | +3.60% | +29.50% |
1st Jan change | Capi. | |
---|---|---|
+29.50% | 8.75M | |
-27.16% | 9.96B | |
-8.84% | 3.03B | |
+34.38% | 3B | |
-14.73% | 2.18B | |
-14.32% | 1.76B | |
+64.43% | 1.42B | |
+25.17% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |